[{"AccountsPayableCurrent_0_Q3_USD":7942000.0,"OtherNoncashIncomeExpense_3_Q3_USD":13000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_3_Q3_USD":7220000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":423000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":363000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":4016000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.01,"PreferredStockSharesAuthorized_0_Q3_shares":1250000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7433000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":0.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":2501000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1014000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1489000.0,"ProductWarrantyAccrual_0_Q3_USD":0.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-467000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-467000.0,"InventoryWriteDown_3_Q3_USD":3702000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":352930000.0,"LiabilitiesCurrent_0_Q3_USD":28771000.0,"MarketableSecuritiesCurrent_0_Q3_USD":null,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-6839000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-1878000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":3925000.0,"NetIncomeLoss_3_Q3_USD":9927000.0,"NetIncomeLoss_1_Q3_USD":558000.0,"OperatingIncomeLoss_1_Q3_USD":1300000.0,"OperatingIncomeLoss_3_Q3_USD":11738000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":19638000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":21397000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":17339000.0,"OtherAssetsNoncurrent_0_Q3_USD":23671000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-777000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":12795000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":49111000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":4654000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":1184992.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":39.65,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_3_Q3_shares":304172.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_3_Q3_USD":44.01,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":34.62,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":44.32,"StockholdersEquity_0_Q3_USD":290060000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":27851.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q3_USD":0.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":373000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q3_shares":218000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_Q3_shares":199000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":14588000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":14647000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":1184992.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":-60000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":4654000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":37.67,"ResearchAndDevelopmentExpense_1_Q3_USD":7673000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":21327000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":231371000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":39536000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":111973000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":220000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":17500000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":53664000.0,"ShareBasedCompensation_3_Q3_USD":7919000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":1900000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":812000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":234000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":177604.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":493628.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q3_USD":39.65,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":16084000.0,"InventoryNoncurrent_0_Q3_USD":22795000.0,"InventoryNet_0_Q3_USD":35019000.0,"CapitalLeaseObligationsIncurred_3_Q3_USD":220000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":90976000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":90976000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-4841000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CommonStockSharesAuthorized_0_Q3_shares":90000000.0,"CommonStockSharesIssued_0_Q3_shares":14436000.0,"CommonStockSharesOutstanding_0_Q3_shares":14436000.0,"CommonStockValue_0_Q3_USD":144000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":91000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":9150000.0,"ContractWithCustomerLiability_0_Q3_USD":900000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":16513000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":47164000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":195000.0,"CostsAndExpenses_1_Q3_USD":21723000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":0.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":-21920000.0,"AccountsReceivableNetCurrent_0_Q3_USD":32352000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":17339000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":2046000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-5319000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":63864000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":71000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2863000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":7919000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":1358000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":2000000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":5900000.0,"Assets_0_Q3_USD":352930000.0,"AssetsCurrent_0_Q3_USD":165780000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":0.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q3_USD":-3450000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":3490000.0,"CostsAndExpenses_3_Q3_USD":53071000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":1018000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":12972000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":1252000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":11597000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":694000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":1670000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-702000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":8321000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_3_Q3_USD":-423000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":3104000.0,"IncreaseDecreaseInInventories_3_Q3_USD":7117000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-1864000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q3_USD":112736000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":85021000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":-48000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":-141000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":28935000.0,"ImpairmentOfIntangibleAssetsFinitelived_3_Q3_USD":0.0,"GrossProfit_3_Q3_USD":64809000.0,"GrossProfit_1_Q3_USD":23023000.0,"GoodwillImpairmentLoss_3_Q3_USD":0.0,"DepreciationAndAmortization_3_Q3_USD":4702000.0,"EarningsPerShareBasic_1_Q3_USD":0.04,"EarningsPerShareBasic_3_Q3_USD":0.69,"EarningsPerShareDiluted_1_Q3_USD":0.04,"EarningsPerShareDiluted_3_Q3_USD":0.68,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.554,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.144,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":14389000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":-49000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":2494000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":210000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":24584000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-831000.0,"Goodwill_0_Q3_USD":7950000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":-463000.0,"GoodwillImpairmentLoss_1_Q3_USD":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":8794000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":14429000.0,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]